A 38-year-old man presents with bilateral nasal obstruction and rhinorrhea for 6 months. Nasal endoscopy reveals bilateral pale, smooth, pedunculated masses arising from the lateral nasal wall. Biopsy confirms benign inflammatory nasal polyps. What is the drug of choice for medical management before considering surgical intervention?

Explanation

## Medical Management of Benign Nasal Polyps **Key Point:** Intranasal corticosteroids are the first-line medical therapy for benign inflammatory nasal polyps, with the goal of reducing polyp size and delaying surgical intervention. ### Mechanism of Action Intranasal corticosteroids (e.g., mometasone furoate, fluticasone propionate, beclomethasone) reduce mucosal inflammation, decrease mucus secretion, and promote polyp shrinkage through: - Suppression of eosinophilic infiltration - Reduction of inflammatory cytokines (IL-4, IL-5) - Decreased vascular permeability ### Dosing & Duration - **Mometasone furoate**: 50 µg per nostril, 1–2 sprays twice daily - **Fluticasone propionate**: 50 µg per nostril, 1–2 sprays once or twice daily - Minimum trial: **8–12 weeks** before assessing response - Some polyps regress completely; others shrink sufficiently to defer surgery **High-Yield:** Intranasal corticosteroids reduce polyp size in 50–70% of patients and can delay or eliminate the need for surgery in mild-to-moderate cases. ### When Surgery Is Indicated - Failure of medical management after 3 months of adequate intranasal corticosteroid therapy - Severe obstruction affecting quality of life or sleep - Recurrent acute sinusitis despite medical therapy - Suspicion of malignancy (atypical presentation, unilateral polyp) **Clinical Pearl:** Post-operative intranasal corticosteroids reduce recurrence rates from ~30% to ~10–15%, making them essential for long-term control even after endoscopic sinus surgery (ESS). ### Why Other Options Fail | Drug Class | Reason Not First-Line | |---|---| | Oral antihistamines (cetirizine) | Minimal effect on polyp size; only symptomatic relief of allergic rhinitis if coexistent | | Topical decongestants (xylometazoline) | Temporary mucosal vasoconstriction; no anti-inflammatory effect; risk of rebound congestion | | Antibiotics (amoxicillin-clavulanate) | Only indicated if secondary bacterial infection; benign polyps are non-infectious | [cite:Dhingra 7e Ch 5]